vTv Therapeutics (VTVT) Institutional Ownership

vTv Therapeutics logo
$17.29 -0.40 (-2.26%)
Closing price 04:00 PM Eastern
Extended Trading
$17.06 -0.23 (-1.33%)
As of 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for vTv Therapeutics (NASDAQ:VTVT)

Current
Institutional Ownership
Percentage
17.51%
Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$3.29M
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$837.09K
Get VTVT Insider Trade Alerts

Want to know when executives and insiders are buying or selling vTv Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

VTVT Institutional Buying and Selling by Quarter

vTv Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2026 Samsara Biocapital LLC354,730$10.94M1.0%+18.8%9.003%
11/14/2026 Marshall Wace LLP23,883$737K0.0%-39.6%0.606%
11/12/2026 State Street Corp13,066$403K0.0%-46.7%0.332%
10/28/2026 China Universal Asset Management Co. Ltd.5,360$161K0.0%+114.4%0.000%
2/18/2026 683 Capital Management LLC18,268$731K0.0%N/A0.464%
2/10/2026 Goldman Sachs Group Inc.5,531$221K0.0%N/A0.140%
2/9/2026 Geode Capital Management LLC28,194$1.13M0.0%+84.3%0.716%
11/17/2025 Millennium Management LLC12,935$301K0.0%-14.0%0.328%
11/17/2025 Baker BROS. Advisors LP148,314$3.46M0.0%+52.4%3.766%
5/14/2025Connective Capital Management LLC9,377$162K0.1%N/A0.294%
2/12/2025Geode Capital Management LLC11,634$158K0.0%+12.9%0.365%
2/12/2025JPMorgan Chase & Co.1,803$25K0.0%N/A0.057%
11/13/2024FMR LLC178,200$2.40M0.0%N/A5.920%
5/15/2024Baker BROS. Advisors LP97,314$2.29M0.0%N/A3.233%
11/8/2023Pathstone Family Office LLC242,937$116K0.0%N/A0.232%
2/9/2023HBK Sorce Advisory LLC57,694$38K0.0%N/A0.055%


VTVT Institutional Ownership - Frequently Asked Questions

During the previous two years, 11 institutional investors and hedge funds held shares of vTv Therapeutics. The most heavily invested institutionals were Samsara Biocapital LLC ($10.94M), Baker BROS. Advisors LP ($3.46M), Geode Capital Management LLC ($1.13M), Marshall Wace LLP ($737K), 683 Capital Management LLC ($731K), State Street Corp ($403K), and Millennium Management LLC ($301K).Learn more on vTv Therapeutics' institutional investors.

17.51% of vTv Therapeutics' stock is owned by institutional investors. Learn more on VTVT's institutional investor holdings.

The following institutional investors have purchased vTv Therapeutics' stock in the last 24 months: Samsara Biocapital LLC ($56.23K), Baker BROS. Advisors LP ($51K), 683 Capital Management LLC ($18.27K), Geode Capital Management LLC ($14.22K), Connective Capital Management LLC ($9.38K), Goldman Sachs Group Inc. ($5.53K), and China Universal Asset Management Co. Ltd. ($2.86K).

Institutional investors have bought a total of 95,789 shares in the last 24 months. This purchase volume represents approximately $3.29M in transactions.

The following institutional investors have sold vTv Therapeutics stock in the last 24 months: Marshall Wace LLP ($15.68K), and State Street Corp ($11.47K).

Institutional investors have sold a total of 27,143 shares in the last 24 months. This volume of shares sold represents approximately $837.09K in transactions.



Institutional ownership data for NASDAQ:VTVT is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 11/17/2026. New 13F filings are added each quarter as they're published.
From Our Partners